Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-κB binding to its recognition sequence

Atherosclerosis

Volumn 158, Issue 1, 2001, Pages 121-128

  Otsuki, Michio ^a   Saito, Hiroshi ^a   Xu, Xin ^a   Sumitani, Satoru ^a   Kouhara, Haruhiko ^a   Kurabayashi, Masahiko ^b   Kasayama, Soji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Cilostazol; Endothelium; Vascular cell adhesion molecule 1

Indexed keywords

CILOSTAZOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL ADHESION; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

CELL ADHESION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; NF-KAPPA B; PHOSPHODIESTERASE INHIBITORS; RNA, MESSENGER; TETRAZOLES; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0034904647     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00431-2     Document Type: Article

References (41)

1. Effect of cilostazol on platelet aggregation and experimental thrombosis
2. Hemodynamic effect of cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans
3. Cilostazol has beneficial effects in treatment of intermittent claudication
4. Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new inhibitor sepharose chromatography
5. Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortie smooth muscle cells in culture
6. Effects of a single local administration of cilostazol on neointimal formation in balloon-injured rat carotid artery
7. Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty
8. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty
9. Atherosclerosis - An inflammatory disease
10. Endothelial-leukocyte adhesion molecules in human disease
11. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis
12. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques
13. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques
14. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis
15. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
16. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
17. Rapid detection of octamer binding proteins with ']mini-extracts' prepared from a small number of cells
18. Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells
19. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1)
20. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells
21. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1)
22. Functional analysis of the human vascular cell adhesion molecule 1 promoter
23. NF-κB: A lesson in family values
24. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site
25. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1
26. Action of cAMP on expression and release of adhesion molecules in human endothelial cells
27. Regulation of tumor necrosis factor-α and interleukin-1β induced adhesion molecule expression in human vascular smooth muscle cells by cAMP
28. Activation of NF-κB by cAMP in human myeloid cells
29. cAMP-induced NF-κB (p50/rel B) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation
30. Increased interleukin-6 production in mouse osteoblastic MC3T3-El cells expressing activating mutant of the stimulatory G protein
31. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells
32. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription
33. Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells
34. The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man
35. Effect of cilostazol on the production of platelet-derived growth factor in cultured human vascular endothelial cells
36. Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-α in vascular endothelial cells
37. Role of hepatocyte growth factor in endothelial regulation: Prevention of high D-glucose-induced endothelial cell death by prostglandins and phosphodiesterase type 3 inhibitor
38. Cilostazol lipid investigators study group
39. Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes
40. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients
41. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis